Labrador, Baby Boy .

HRN: 28-75-60  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
03/27/2026
04/06/2026
PO
3ml
TID
Amoebiasis
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamIntra-abdominalProphylaxis    Compliance to guidelines: